About
SPR-MS provides MALDI and label-free, real-time SPR-based mass spectrometry services for the characterization of protein-protein interactions. Additionally, available technologies include ESI mass spectrometry and multiplexing.
Leadership Team
Scientific Co-Director
Gerhard Multhaup, PhD
Scientific Co-Director
Jean-François Trempe, PhD
Platform Manager
Mark Hancock, PhD
Tags: Department of Pharmacology & Therapeutics, transmission electron microscopy, TEM, pre-embedding immunocytochemistry, post-embedding immunocytochemistry, flat embedding, epoxy resin, methacrylate resin, negative staining, ultramicrotomy, processing cells & tissues, Imaging & Molecular Biology Platform, IMBP, Confocal and Two-Photon Microscopy, High Content Imaging, PCR, qPCR, Bioanalyzer, Microarray, Pyrosequencing, McGill SPR-MS Facility, surface plasmon resonance, SPR, BIACORE 3000, BIACORE T200, mass spectrometry, MS, Bruker UltrafleXtreme, MALDI-TOF/TOF, MALDI tissue imaging, mass spectrometry imaging, IMS, MSI, top-down sequencing, TDS, in-source decay, ISD, Bruker Impact II, ESI-qTOF, LC-MS, LC-MS/MS, in-gel trypsin digestion, in-solution trypsin digestion.
